Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
Gary C. Bhojwani, Chief Executive Officer and Director of CNO Financial Group, Inc. (CNO), reported multiple gifts of company common stock executed on 08/12/2025. The filing shows disposals by gift: 3,092 shares from personal holdings (reported at $0 per share), 5,904 shares from the Gary C. Bhojwani Revocable Trust (reported at $0), and a further 195,926 shares disposed (listed as a disposal). After the reported transactions, the filing records 698,331 shares beneficially owned following the first disposal, held indirectly. The form is signed by an attorney-in-fact on 08/14/2025. All transactions are labeled as gifts in the explanation.
Form 144 notice for proposed sale of CNO Financial Group, Inc. securities. The filing shows an intended sale of 4,862 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $184,655.84 and 96,931,934 shares outstanding. The approximate date of sale is listed as 08/14/2025 on the NYSE.
The filer reports acquisition details: 1,478 performance shares acquired 02/15/2024 and 3,384 restricted shares acquired 08/09/2024, both from the issuer. The filing also discloses sales during the past three months by Jeanne Linnenbringer totaling 6,420 common shares sold on 08/13/2025 with gross proceeds of $167,782.76 and $75,919.80.
Certain filer and issuer identifying fields (CIK, issuer name, contact details) are not populated in the provided text.
CNO Financial Group Form 144 discloses a proposed sale of common stock: 9,920 shares with an aggregate market value of $376,551.30, to be executed on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. The filing records 96,931,934 shares outstanding.
The shares were acquired from the issuer on 02/15/2024 as performance shares and payment is shown as Not Applicable. The filer reports Nothing to Report for securities sold during the past three months and makes the standard representation that they are not aware of undisclosed material adverse information about the issuer.
Form 144 notice for CNO Financial Group (CNO) reports a proposed sale of 6,420 common shares with an aggregate market value of $243,702.56. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. Total shares outstanding reported are 96,931,934, giving readers the raw figures needed to assess scale.
The filing shows how the securities were acquired: 2,000 shares were restricted stock granted on 08/09/2024 and 4,420 were from a stock option exercise on 08/13/2025 paid in cash. The filer reports no sales in the past three months.
CNO Financial Group filed a Form S-8 to register an additional 2,000,000 shares of common stock for issuance under its Amended and Restated Long-Term Incentive Plan. The board adopted the amendment on February 12, 2025 and stockholders approved it on May 8, 2025. The amendment increases the number of shares reserved and the number of incentive stock options that may be granted by 2,000,000 shares and extends the plan termination to the day immediately prior to the tenth anniversary of stockholder approval.
The filing omits Part I prospectus text under Rule 428 and incorporates prior S-8 registration statements and recent Exchange Act filings by reference, including the Annual Report for the year ended December 31, 2024 (filed February 26, 2025) and quarterly reports filed May 7, 2025 and August 6, 2025.
CNO Financial Group, Inc. filed a Form S-8 to register an additional 1,600,000 shares of its common stock for issuance under the Amended and Restated Employee Stock Purchase Plan. The board adopted the amendment and restatement of the Plan on February 12, 2025, and the company’s stockholders approved the amendment on May 8, 2025. The additional shares increase the number of shares reserved for the Plan relative to the shares previously registered under the company’s prior Form S-8 (File No. 333-224819).
The Registration Statement incorporates by reference the company’s recent annual and quarterly reports and specified current reports, and it describes the company’s Delaware-based indemnification provisions and directors’ and officers’ insurance. The filing lists key exhibits, including the Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws, the ESPP document incorporated by reference, legal opinions and consents.
CNO Financial Group, Inc. filed a Form 13F reporting institutional holdings totaling $161,755,421 across 14 reported positions. The filing lists 40|86 Advisors, Inc. as an other included manager and was signed by Joel T. Koehneman, Senior Vice President and Chief Accounting Officer, on 08-08-2025.